Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:RCUS
NYSE:RCUSBiotechs

Arcus Biosciences (RCUS): Projected 33.2% Revenue Growth Challenges Persistent Unprofitability Narrative

Arcus Biosciences (RCUS) remains in the red, with losses deepening at a 26% annual rate over the past five years and no profitability expected for at least the next three. Its net profit margin has shown no sign of turning around, and the company does not boast high-quality past earnings. Still, revenue is projected to surge by 33.2% annually, soundly outpacing the US market’s 10.2% growth forecast and suggesting a rapid top-line trajectory for this biotech name. See our full analysis for...
NasdaqGS:RCKY
NasdaqGS:RCKYLuxury

Rocky Brands (RCKY) Margin Gains Challenge Cautious Narratives Despite Slower Revenue Growth

Rocky Brands (RCKY) reported net profit margins of 4.4%, up from last year’s 2.9%, with EPS growth of 54.6% over the past year. This strong bottom-line delivery outpaces the company’s five-year average decline of 9.9% per year, and value investors will note shares currently trade at a discounted 10.6x P/E compared to industry averages and the company’s estimated fair value. With recent margin improvements and a solid track record of dividends, the latest results provide reasons for optimism,...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

Kiniksa Pharmaceuticals (KNSA) Profit Surge Challenges Valuation Caution as Growth Outpaces Peers

Kiniksa Pharmaceuticals International (KNSA) turned profitable in the last year, with net profit margins improving and earnings growing at a 40.7% annual rate over the past five years. Looking ahead, analysts expect earnings to climb another 33.3% per year on average for the next three years. This is notably faster than both the US market and the company’s own revenue forecast, which is set at 16.7% annual growth. These trends position the company as one with robust ongoing momentum and...
NasdaqCM:SMLR
NasdaqCM:SMLRMedical Equipment

Semler Scientific (SMLR): Revisiting Valuation Following DOJ Probe and Class Action Lawsuit Announcements

Semler Scientific (SMLR) is drawing attention after a wave of class action lawsuits was announced. These lawsuits focus on claims that the company did not disclose a significant Department of Justice investigation into possible False Claims Act violations. See our latest analysis for Semler Scientific. After a rough patch that saw Semler Scientific’s share price tumble over the past year, market momentum turned turbulent again following news of the DOJ probe and a CFO departure. While the...
NYSE:CTO
NYSE:CTOREITs

CTO Realty Growth (CTO): Losses Worsen as Unprofitability Persists, Challenging Value-Driven Narratives

CTO Realty Growth (CTO) remains in the red, with losses widening at an annual rate of 67.6% over the past five years and no improvement in net profit margin or overall profitability. While the company’s revenue is expected to grow by 6.8% per year, that pace lags behind the broader U.S. market’s 10.2% per year, and earnings are forecast to stay negative for at least the next three years. For investors, the potential reward is that shares are currently trading well below one estimate of fair...
NasdaqGS:ZEUS
NasdaqGS:ZEUSMetals and Mining

Olympic Steel (ZEUS): Net Margin Decline Reinforces Concerns Over Valuation and Growth Narratives

Olympic Steel (ZEUS) posted revenue that is forecast to grow at 2.8% per year, trailing the broader US market’s projected 10.2% annual rate. Net profit margins currently stand at 0.7%, down from last year’s 1.3%, and the company experienced negative earnings growth over the past year, despite a five-year transition to profitability. With the share price trading above estimated fair value at $36.84 per share and a price-to-earnings ratio of 29.9x, investors now face the question of whether the...
NasdaqGS:ILPT
NasdaqGS:ILPTIndustrial REITs

Industrial Logistics Properties Trust (ILPT): Losses Deepen 41.5% Per Year, Testing Value Narrative

Industrial Logistics Properties Trust (ILPT) has seen losses deepen over the past five years, with annual losses increasing by 41.5%. The company remains unprofitable and is expected to continue operating at a loss for at least the next three years. Revenue is forecasted to grow at 3.1% per year, which trails the US market average of 10.2%. As a result, investors face a mix of recognized value given a price-to-sales ratio of 0.8x and a share price of $5.26, which is below the estimated fair...
NasdaqGS:VMEO
NasdaqGS:VMEOInteractive Media and Services

Vimeo (VMEO) Margin Drops Sharply, Challenging Bullish Outlook Despite Strong Profit Growth Forecast

Vimeo (VMEO) is forecasting robust earnings growth of 44.7% per year, well ahead of the broader US market's projected average. Although the company has achieved profitability over the past five years, averaging annual earnings growth of 48.3%, its net profit margin has slipped to 0.3% from last year's 7.9%. Investors are weighing this strong growth outlook against recent margin compression, a one-off $2.2 million loss, and a valuation that looks expensive compared to industry peers, with a...
NYSE:V
NYSE:VDiversified Financial

Visa (V) Margin Compression Undercuts Bullish Profit Narratives Despite Strong Earnings Track Record

Visa (V) posted a net profit margin of 50.1%, down from last year's 54.2%, pointing to margin compression year-over-year. While the company's earnings have grown at an average rate of 14.4% annually over the past five years, recent annual earnings growth slowed to 3.1%, which is notably below its historical pace. Looking forward, earnings are forecast to rise by 11.46% per year and revenue by 9.5% annually, although both are trailing behind broader US market expectations. Visa's consistent...
OM:NYF
OM:NYFReal Estate

Will Nyfosa's (OM:NYF) Return to Profitability on Lower Revenues Shift Its Investment Narrative?

Nyfosa recently reported third quarter earnings for 2025, revealing SEK 887 million in revenue and net income of SEK 295 million, compared to a net loss in the same period last year. This marks a turnaround in profitability for the company, achieved even as sales and revenues were slightly lower than the prior-year period. We'll explore how Nyfosa's return to profitability amid softer revenues could impact the company's overall investment narrative. AI is about to change healthcare. These 34...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

ExlService Holdings (EXLS) Posts 28.5% Earnings Growth, Reinforcing Bullish Investor Narratives

ExlService Holdings (EXLS) reported revenue that is forecast to grow at 10.4% per year, just ahead of the US market’s 10.2%, while net income delivered a standout 28.5% gain over the past year. Over the past five years, earnings have compounded at 19% annually, and net profit margins climbed to 11.9% from 10.6%, marking a further boost in profitability. With no identified risks and several upside factors in play, including favorable valuation metrics and a share price below analyst targets,...
SEHK:3988
SEHK:3988Banks

Bank of China (SEHK:3988) Margins Rise to 43%, Undervaluation Narrative Gains Traction

Bank of China (SEHK:3988) posted a net profit margin of 43% in its latest results, up from 38.4% a year ago, with EPS climbing 15.9% year-over-year. This is well above its 5-year average growth of 4.1% per year. The stock closed at HK$4.44, notably trading below its estimated fair value of HK$9.42, with a price-to-earnings ratio of just 5.5x compared to industry peers. These results highlight consistently strong profitability, improving margins, and valuation appeal that continues to draw...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Enphase Energy (ENPH) Profit Margin Surge Reinforces Bullish Narratives Despite Slower Growth Outlook

Enphase Energy (ENPH) posted a jump in net profit margin to 12.9%, up sharply from 4.9% a year ago. Year-over-year earnings growth reached 218.4%, easily surpassing its five-year earnings growth average of just 3.3% per year. At the same time, the stock trades at a Price-To-Earnings Ratio of 20.8x, notably below both the US semiconductor industry average of 39.8x and its peer group’s 46.9x. Shares are currently priced at $31.14, sitting under the estimated fair value of $38.49. Investors will...